crizotinib for advanced papillary renal cell carcinoma with met mutations or amplification
Published 6 years ago • 283 plays • Length 3:45Download video MP4
Download video MP3
Similar videos
-
2:35
cabozantinib most effective treatment for metastatic papillary kidney cancer
-
2:35
papmet: met inhibitors in treating papillary renal cell carcinoma
-
3:49
cabozantinib benefit for metastatic papillary rcc demonstrated | sumanta pal
-
3:36
sunitinib vs cabozantinib, crizotinib, or savolitinib for metastatic papillary rcc
-
1:26
what is papillary rcc?
-
5:01
papillary kidney cancer clinical trials
-
22:48
comprehensive molecular characterization of papillary renal cell carcinoma - w. marston linehan
-
4:10
renal cell cancer: highlights from asco 2020
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
5:29
first- and second-line treatments for locally advanced renal cell carcinoma
-
6:18
asco 2020: updates in renal cancer
-
2:42
latest from tivo-3: tivozanib for refractory advanced renal cell carcinoma
-
2:03
dr. choueiri on savolitinib in papillary renal cell cancer
-
14:50
rare cancer meta-analysis, pt.1: background on papillary renal cell carcinoma
-
3:59
new options for papillary rcc
-
9:21
updates on papillary renal cell carcinoma from asco gu 2018
-
24:53
systemic treatment options for patients with metastatic non-clear cell renal cell carcinoma
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma